Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
BJUI Compass|April 7, 2023
Serum testosterone and prostate cancer in men with germline <i>BRCA1/2</i> pathogenic variantsAlexander Dias, Mark N Brook, Elizabeth K Bancroft, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
Oncotarget|May 15, 2018
The clinical impact of using complex molecular profiling strategies in routine oncology practiceJean-François Laes, Philippe Aftimos, Philippe Barthelemy, et al.
Journal of Medical Genetics|November 14, 2019
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic <i>TP53</i> mutation carriers: a case-controlled study (SIGNIFY)Elizabeth K Bancroft, Sibel Saya, Emma Brown, et al.
Plos Genetics|February 20, 2014
Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancerEdward J Saunders, Tokhir Dadaev, Daniel A Leongamornlert, et al.
British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
British Journal of Cancer|March 7, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
Pageof 4